News

Berkshire Hathaway gains ground, but still trails the S&P 500 as '26 enters second half

BRK.A

With 2026 a bit more than half over, Berkshire Hathaway's B shares are down 1.8% year-to-date and 12.4 percentage points behind the S&P 500's 10.7% gain.

From booksmaxxing to looksmaxxing: Why the viral trends concern some mental health experts

BPOP, BPOPO

People are self-optimizing everything — protein, skincare, fitness — to such a degree that "maxxing" is one of social media's most popular suffixes.

Bank of America says these stocks are a buy heading into earnings

BAC, 858388

Bank of America named a slew of stocks that are best positioned heading into quarterly reports.

The best states to live in for 2026: No. 1 has a six-year winning streak

2026

Return to office mandates and a decline in remote work have companies looking more closely at the quality of life in the place where they establish offices. 

These are America’s 10 worst states to live in for 2026

10, 2026

Some states may have low costs and light regulation, but high crime and lack of healthcare are among important factors when people choose where to live. 

Ferrari has recovered from its Luce-unveil slump. Why the stock is still underappreciated

Ferrari shares are up 17% since falling after unveiling its panned Luce model. Two banks still see more potential in the stock.

'Funflation' hits home: Why staying in isn't the cost-saver it used to be

Following a wave of price hikes, at-home pastimes like streaming movies or playing video games are pinching pocketbooks.

Reeves tells BBC: Burnham needs worked-through plan to govern from the start

BBC

The Chancellor tells Laura Kuenssberg she will be handing over a stable economy to the incoming PM.

Burnout, frustration and heartbreak: Amazon layoffs take their toll in saturated job market

AMZN, AMZNN, AMZNCL, AMZD, AMZ, 1AMZN, 0R1O, 4AMZN, 0R1OL, AMZNUS

In the eight-plus months since Amazon announced its most expansive job cuts ever, laid off workers have been thrust into an increasingly saturated labor market.

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

GLP, A

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.